Fulton Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Buy |
1,421
+46
| +3% | +$15K | 0.02% | 444 |
|
|
2025
Q1 | $371K | Buy |
1,375
+32
| +2% | +$8.64K | 0.02% | 479 |
|
|
2024
Q4 | $316K | Buy |
1,343
+301
| +29% | +$70.8K | 0.01% | 530 |
|
|
2024
Q3 | $287K | Buy |
1,042
+24
| +2% | +$6.6K | 0.01% | 557 |
|
|
2024
Q2 | $247K | Buy |
+1,018
| New | +$247K | 0.01% | 564 |
|